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This thesis describes the development of diastereo- and enantioselective 
Henry reaction of β-substituted α-keto esters using cinchona alkaloid derived 
bifunctional catalyst via dynamic kinetic resolution. 
Chapter 1 presents a brief historical background and development of 
asymmetric catalysis. Particularly, the asymmetric organocatalysis is introduced in 
detail. Then the historical background and development of dynamic kinetic 
resolution are summarized, especially, those organocatalytic methods are 
introduced in detail. 
In Chapter 2, the diastereo- and enantioselective Henry reactions of 
β-substituted α-keto esters via dynamic kinetic resolution are investigated by 
using cinchona alkaloid derived bifunctional catalysts. Our approach combines 
organocatalytic Henry reaction and concept of dynamic kinetic resolution, and it 
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Chapter 1 introduction 
1.1 Asymmetric catalysis 
1.1.1 Molecular chirality 
Chiral molecules are optically active compounds that lack an internal plane of 
symmetry and have a non-super imposable mirror image.1 Most of natural 
products and pharmaceutical compounds are chiral molecules. About 80% of the 
natural products have at least one chiral center, and 15% of them have 11 or more 
stereocenters.2 Therefore, nowadays asymmetric organic synthesis is becoming an 
extraordinarily important field in medicinal chemistry and pharmaceutical industry. 
Due to the stereoisomers may have different pharmacological effects and activities 
and the enzymatic processes in the body are extremely chiral-selective, one isomer 
could have desired drug activities, while the other one may be inefficient or even 
lead to severe side effects.3,4 Thus, finding more efficient approaches to synthesize 
optically pure compounds is an important target for organic chemists. 
1.1.2 Asymmetric synthesis 
There are two main approaches to adopt in asymmetric synthesis: chiral 
auxiliaries based method and asymmetric catalysis. Chiral auxiliaries used to be 
the main method in asymmetric synthesis5. Some excellent examples include 
Evan’s oxazolidinones6, sulfinamides7, sulfoxids8 and carbohydrate derivatives9. 
However, compared with asymmetric catalysis, chiral auxiliary-based approaches 
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are less efficient due to the post-processing of auxiliaries.  
    The advantage of asymmetric catalysis is apparent. As catalytic reactions, the 
catalysts could be regenerated during the reaction. There are three common 
approaches to perform asymmetric catalysis: enzyme catalysis, transition metal 
mediated catalysis and asymmetric organocatalysis. 
    Enzymes are highly efficient and specific biocatalysts in nature, excellent 
enantioselectivies and high reaction rates are commonplace for enzymatic 
reactions. Traditionally, enzyme catalysis has been utilized for the preparation of 
chiral molecules.10 However, the sensitivity of enzymes to acid, base and 
temperature, as well as the difficulty of generating specific stereoisomers limit 
their applications in asymmetric synthesis. 
Transition metal mediated catalysis has been widely used to obtain excellent 
chiral molecules in the past few decades. For instance, Sharpless and Katsuki 
pioneered enantioselective epoxidation of allylic alcohols with a titanium-tartrate 
complex 1-1 as catalyst.11 Noyori and co-workers greatly advanced asymmetric 
hydrogenation reaction by introducing BINAP 1-2 in metal catalysis.12 Many 
previliged ligands are well-established, including chiral salen Mn complexes 1-3 
for asymmetric epoxidation of alkenes13 and chiral copper complexes 1-4 for 
asymmetric cyclopropanation14. 
Although transition metal mediated catalysis has undoubtedly become the 
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most important approach to obtain optically pure compounds, it still suffers from 
some severe drawbacks, such as toxicity and expensive nature of the metals 


































Scheme 1.1 Structures of some representative ligands. 
1.1.3 Asymmetric organocatalysis 
Compared with transition metal mediated process, organocatalysis relies on 
small chiral molecules without involving metal in the catalytic process. Although 
this emerging field only drew attention from synthetic community in 2000, it 
actually has a long history. In 1908, Breding reported the first decarboxylation 
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reaction with only organic catalysts.15 Subsequently, a kinetic resolution (KR) 
approach of this reaction with chiral alkaloids was published.16 In 1912, Breding 
presented the crucial work of hydrocynation reaction of benzaldehyde. Although 
employment of cinchona alkaloid only led to poor enantioselectities, this work 
was considered as a milestone in the organocatalysis17. In 1929 and 1932, Vavon 
and Vegler reported the acylation of secondary alcohols via kinetic resolution 
(KR), respectively.18 
The next breakthrough of organocatalysis came in 1950s when Stork and 
co-workers introduced the utilization of enamines as nucleophiles.19 In 1970s the 
so-called Hajos-Parrish-Eder-Sauer-Wiechert reaction was reported, which has a 
key intramolecular aldol reaction catalyzed by L-proline via enamine 
intermediates.20 
In 1960, Pracejus reported the addition of methanol to methyl phenyl ketene 
catalyzed by O-acetylquinine.21 Wynberg and co-workers did a series of 
modification on the C-9 hydroxyl group of cinchona alkaloids, by employing such 
catalysts, they were able to perform asymmetric 1,2- and 1,4- nucleophilic 
additions of carbonyl compounds.22 
The main development of this field in next two decades is ion-pairing 
mediated approach, which includes phase-transfer catalysis23 and Bronsted acids 
catalyzed processes24. 
























































1-11 1-12 1-13  
Scheme 1.2 Selected representative organocatalysts. 
The year 2000 saw the rebirth of modern organocatalysis. In the past decade, 
significant contributions from the groups of Jacobsen25-27, List28-33, MacMillan34-36, 
Maruoka37-41 and Denmark42-45 greatly advanced the field. Some representative 
catalysts are shown in Scheme 1.2, which includes cinchona alkaloid derivatives 
1-5 and 1-8, chiral BINOL derivative 1-6, L-proline derivative 1-7, oxazolidinone 
1-9, phase-transfer catalyst 1-10, chiral imidazole derivative 1-11, chiral DMAP 
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derivative 1-12 and thiourea derivatives 1-8 and 1-13. 
    Compared with transition metal catalysts, organocatalysts are often more 
stable to moisture and air. Moreover, they are typically inexpensive, easy to 
prepare and less toxic. Thus, organocatalysis not only gained popularity in 
academic research, but also have a bright future in industrial applications. 
1.2 Dynamic Kinetic Resolution (DKR) 
1.2.1 Introduction 
Resolution of racemates is the most important industrial approach to the 
synthesis of optically pure compounds. The traditional kinetic resolution is 
defined as the two enantiomes of a racemate are transformed to products in 




SR, SS = substrate enantiomers
PR, PS = product enantiomers  
Figure 1.1 Traditional kinetic resolution. 
As shown in Figure 1.1, an efficient kinetic resolution could be described as 
one of the enantiomers is fully transformed to the desired product while the other 
is retained. Thus, kinetic resolution has the maximum theoretical yield of 50%. 
To overcome the limitation of yield without lose enantioselectivity, dynamic 
kinetic resolution (DKR) was introduced. As shown in Figure 1.2, with an in situ 
equilibration or racemization of the chirally-labile substrate, one of the 
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enantiomers can be obtained in a theoretical yield of 100%. 47 
SR PRfast
SlowSS PS
SR, SS = substrate enantiomers






Figure 1.2 Dynamic kinetic resolution. 
Harada and co-workers presented the first chemical dynamic kinetic 
resolution of β-keto ester reduction in 197948, as shown in Scheme 1.3. For an 
efficient DKR, the product could not racemize under the reaction conditions and 













































    Scheme 1.3 Asymmetric hydrogenation of β-keto ester via DKR 
Moreover, the rate constant for the racemization (kinv) should be faster than 
that of resolution step (kA), otherwise a high selectivity must be ensured. 
Racemization of the substrate can be performed chemically, biocatalytically or 
spontaneously.47 DKR is not limited to synthesis an enantiomer with only one new 
chiral center, when the reaction occurs along with the creation of a new 
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stereogenic center, an enantioselective synthesis of a diastereoisomer is also 
possible.49 
Organocatalysts have some important advantages, such as stable, inexpensive, 
readily available and non-toxic. Recently, organocatalytic DKR has received more 
and more attention. Some recent examples will be illustrated in the following 
section. 
1.2.2 Organocatalytic DKR 
In 2001, Deng and co-workers reported an organocatalytic DKR reaction50, 
as shown in Scheme 1.4. The asymmetric alkylation of N-carboxyanhydrides was 
achieved by using cinchona alkaloid derivatives as catalysts. In this process, 
(DHQD)2AQN 1-25 acts as a bifunctional catalyst to catalyze both racemization 
and alcoholytic kinetic resolution of alkyl N-carboxyanhydrides with an 
electron-withdrawing N-protecting group, leading to the generation of the 
corresponding amino esters in good yields and high enantioselectivities. 
 




Scheme 1.4 DKR process of N-carboxyanhydrides catalyzed by Cinchona 
alkaloid derivatives. 
In 2004, Walsh and co-workers developed L-proline catalyzed aldol reactions 
of atropisomeric amides. As shown in Scheme 1.5, the DKR process 
simultaneously established the stereoselectivies of the atropisomeric amide chiral 
axis and also a new stereogenic center was formed from the asymmetric aldol 
reaction.51 
 




Scheme 1.5 L-Proline catalyzed DKR process of atropisomeric amides. 
In 2004, Krische and co-workers employed tertiary phosphine catalyst 1-31 
in the reactions of Morita-Baylis-Hillman acetates and phthalimide (Scheme 1.6), 
the reaction was believed to proceed through a tandem SN2’- SN2’ mechanism and 
moderate enantioselectivities were obtained.52 




Scheme 1.6 Tertiary phosphine catalyzed Morita-Baylis-Hillman reaction via 
DKR. 
The first catalytic asymmetric synthesis of sulfinate esters through DKR was 
reported by Ellman and co-workers in 2004. The N-methyl imidazole-containing 
octapeptide 1-34 was introduced as the catalyst, and high enantioselectivities were 
achieved from racemic tert-butanesulfinyl chloride.53 By employing cinchona 
alkaloid derivatives as the catalyst, Toru and co-workers obtained good results in 
similar reactions (Scheme 1.7).54 Sulfone enolates were considered as the 
racemization intermediates in this reaction in the presence of organic base. In 
2009, Ellman and co-workers employed quinidine as the catalyst to extend the 
scope of this reaction to include various alcohols, and high yields and 
enantioselectivities were obtained (Scheme 1.8).55 
























R = Ph: yield 93% ee = 88%
R = p-ClC6H4: yield 78% ee = 88%
R = p-MeOC6H4: yield 70% ee = 99%
R = 4-MeO-3-MeC6H4: yield 78% ee = 93%
R = 2,4,6-(Me)3C6H2: yield 68% ee = 92%
 
Scheme 1.7 Organocatalyzed DKRs of sulfinyl chlorides. 




Scheme 1.8 DKRs of tert-butanesulfinyl chlorides. 
In 2005, Berkessel and co-workers reported a highly enantioselective DKR 
alcoholysis of azlactones catalysed by thiourea bifunctional catalysts. As shown in 
Scheme 1.9, this work provided a direct method to synthesis a wide range of 
protected natural and non-natural α-amino acids with high enantioselectivities.56 
In 2006, the same group also explored various bifunctional thiourea catalysts and 
extended the substrate scope of this DKR process.57 
 




Scheme 1.9 Thiourea catalyzed DKR processes of azlactones 
An asymmetric direct aldol reaction was reported by Ward and co-workers in 
2005. As shown in Scheme 1.10, they introduced that L-proline-catalyzed aldol 
reaction of tetrahydro thiopyranone with racemic aldehyde 1-43 and 1-45 
generated single adducts with excellent enantioselectivities.58 With the more 
soluble L-proline derivatives as the catalyst, the results of these reactions could be 
further improved to 75% yield and >98% ee, and the key intermediate for the total 
synthesis of a sex hormone serricornin was prepared.59 




Scheme 1.10 L-Proline catalyzed direct asymmetric aldol reactions via DKR. 
Substance P is an undecapeptide that functions as a neurotransmitter and as a 
neuromodulator which belongs to the tachykinin neuropeptide family.60 Substance 
P antagonists are used to treat many ailments ranging from gastrointestinal and 
central nervous system disorders to inflammatory diseases, pain, and migraine. An 
efficient synthesis of a pivotal precursor to substance P antagonists had been 
developed by Seemayer and co-workers in 200661, in which L-tartaric acid was 
used to achieve the DKR of benzhydryl quinuclidinone (Scheme 1.11). 
 
Scheme 1.11 DKR of benzhydryl quinuclidinone catalysed by L-tartaric acid. 
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The first highly enantioselective cyanocarbonation of prochiral ketones 
catalyzed by cinchona alkaloid derivatives was reported by Deng and 
co-workers62. As shown in Scheme 1.12, the reported method employed sterically 
hindered simple dialkyl ketones and generated corresponding cyano esters with 
high yield and enantioselectivites, which complemented the known substrate 
scope of enzymatic and transition metal mediated methods. In the proposed 
mechanism, as shown in Figure 1.3, the enantioselectivity determination step in 
the cyanocarbonation was the DKR of the proposed intermediates 1-55 and 1-56 
via asymmetric transfer of the alkoxycarbonyl group. The racemization of 1-55 
and 1-56 is due to that the cyanide addition to ketone is a reversible reaction. 
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Scheme 1.12 Cyanocarbonation of ketones via DKR. 
The catalytic asymmetric reductive amination of carbonyl compounds is a 
classic and powerful C-N bond formation reaction. However, literature reports on 
this topic are rather limited.63 In 2006, List et al. employed BINOL phosphoric 
acid for the asymmetric reductive aminations of aldehydes using a BINOL 
phosphoric acid catalyst 1-52 and Hantzsch esters 1-53 (Scheme 1.13).64 
 
Figure 1.3 Proposed mechanism of cyanocarbonation of ketones via DKR. 




Scheme 1.13 Reductive amination of aldehydes via DKR. 
Hayakawa and co-workers have reported the first asymmetric synthesis of a 
P-chiral trialkyl phosphate from a trialkyl phosphite.65 As shown in Scheme 1.14, 
the key step of this reaction was the DKR in the condensation between the dialkyl 
phosphorochloridite and hydroxyl group catalyzed by cinchona alkaloid 
derivatives. 

































Scheme 1.14 Cinchona alkaloid catalyzed DKR of phosphorochloridite. 
In 2007, Zhang and co-workers reported a L-proline-catalyzed DKR of 
asymmetric aldol reaction between β-substituted α-keto esters and acetone and the 
desired aldol products were obtained in good yields, low diastereoselectivity and 
up to 99% ee.66 In 2009, the same group reported a similar work with employment 
of different substrates, and more than 99:1 diastereomeric ratio with high 
enantioselectivties was obtained.67 In 2010, they further extended the substrate 
scope by including β-cyano α-keto ester in the asymmetric aldol reaction through 
DKR (Scheme 1.15). 




Scheme 1.15 Asymmetric aldol reactions of α-keto esters via DKR. 
Recently, the Birman group disclosed an organocatalytic DKR reaction 
between azlactones 1-64 and bis(1-naphthyl)methanol 1-65.68 An array of chiral 
amidine-based catalysts was investigated, among which the best one was chiral 
benzotetramizole 1-66 (Scheme 1.16). 




Scheme 1.16 Benzotetramizole catalyzed DKR of azlactones. 
In 2010, Qu and co-workers showed that an enantioselective acylation 
catalyzed by 1-70, in combination with a DABCO-mediated racemization of the 
substrates, led to the efficient DKR process (Scheme 1.17).69 Both cyclic and 
acyclic meso-1,2-diol monodichloroacetates 1-68 could be transformed to the 
corresponding enantiomerically enriched diol esters 1-69. The authors proposed 
the DKR on the basis of racemization of the unreacted 1-68 via an intramolecular 
chloroacetoxy migration process. 


































    Scheme 1.17 Thioamide catalyzed DKR of meso-1,2-diol 
monodichloroacetates. 
Recently, peptide-catalyzed asymmetric bromination of biaryl atropisomers 
via DKR was reported by Miller and co-workers.70 The reaction proceeded via an 
atropisomer selective electrophilic aromatic substitution reaction using 
N-bromophthalimide. As shown in Scheme 1.18, the chiral brominated biaryl 
products 1-74 could be obtained with excellent enantioselectivites. In a rationale 
of the observed high enantioselectivity, it was proposed that starting atropisomers 
rapidly interconverted with a barrier to atropisomer interconversion estimated to 
be ~30 kcal mol-1 (for R1=R2=H), whereas the corresponding triply bromiated 
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product 1-74 exhibited much more restricted rotation. 
 
 
Scheme 1.18 Tripeptide catalyzed bromination via DKR. 
Scheidt and co-workers described a new catalytic DKR with N-heterocyclic 
carbenes (NHC) as an efficient approach to synthesize highly 
substituted β-lactones.71 As shown in Scheme 1.19, this reported process 
leveraged the basic conditions necessary to generate the NHC catalyst from the 
azolium salt to promote racemization of the β-keto ester substrates. 
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    Scheme 1.19 NHC catalyzed dynamic kinetic resolution. 
The scope of reductive amination of α-substituted ketones via DKR was 
extended by List and co-workers in 2010.72 They showed substituted 
cyclohexanones 1-77 were ideal substrates for this reaction, and both aromatic and 
aliphatic substituents allow the corresponding products 1-78 to be obtained with 
high yields, diastereoselectivites and enantioselectivities (Scheme 1.20). 
 
Scheme 1.20 Reductive aminations of cyclohexanones via DKR. 
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1.3 Project objectives 
Dynamic kinetic resolution (DKR) is an efficient tool in asymmetric 
synthesis and at the outset of our work, there was no report on asymmetric Henry 
reaction via DKR.  
The main aim of this project was to utilize DKR in Henry reaction between 
β-substituted α-keto ester and nitromethane to develop a diastereoselective and 
enantioselective process. Given the important synthetic applications of nitroalkane 
compounds, we anticipate our approach will provide easy access to a range of 
biologically important molecules, particularly those containing nitrogen atoms. 
In chapter 2, diastereo- and enantioselective organocatalytic Henry reactions 
of β-substituted α-keto esters via DKR will be described in detail. 
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Chapter 2 Asymmetric organocatalytic Henry reactions of 
β–substituted α-keto esters via dynamic kinetic resolution. 
2.1 Introduction 
Dynamic kinetic resolution (DKR) is a powerful approach to obtain highly 
enantioselective products from racemic starting materials, which avoids the 
shortages of kinetic resolution. DKR needs the in situ equilibration or 
racemization of the starting materials in the process and the products cannot 
racemize in such conditions. Theoretically, quantitative yield with 100% 
enantiomeric excess (ee) can be achieved.46, 47 If the second chiral center is 
generated in the reaction, high enantioselectivity of one diastereoisomer is also 
possible49. Recently, increasing attentions has been focused on the acquisition of 
highly enantio-rich reactions via this effective resolution. 
As a classic carbon–carbon bond formation reaction in organic chemistry, 
Henry reaction or nitroaldol reaction yield nitroalkances, which are important 
synthetic intermediates.73 Typically, aldehydes react with nitromethane in the 
presence of chiral metal complexes or chiral phase transfer catalysts.74-79 Deng 
and co-workers employed cinchona alkaloid derivatives as catalysts for the Henry 
reaction of nitroalkanes with ketoesters (Scheme 2.1).80 Takemoto’s group81 and 
Jacobsen’s group82 also employed thiourea derivatives 2-4a and 2-4b as catalysts 
in the asymmetric Henry reaction. Prior to these reports, enantioselectivity of 
Henry reaction was very poor (<54% ee). 83 




Scheme 2.1 Asymmetric catalytic Henry reaction of α-keto esters. 
 
Scheme 2.2 The racemization of selected β-substituted α-keto esters 





































Figure 2.1 Some useful pyrrolidine derivatives. 
Till now, the Henry reactions through DKR process still have not been 
reported. The ester group activates the ketone as an electron-withdrawing group. 
Thus, α-keto ester is more active for Henry reaction than normal ketone. With next 
to a configurationally labile stereogenic center, the activate carbonyl group could 
participate Henry reaction via DKR. With β-aroyl and methyl di-substituted, the 
α-keto ester could establish the fast in situ equilibrium of keto-enol tautomerism. 
Therefore, by using well-designed catalyst, DKR process could be achieved for 
good diastereoselectivies67. There exist two enol forms of this series of our 
selected substrates (Scheme 2.2)84. As shown in Scheme 2.3, due to the good 
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performance of cinchona alkaloid derivatives in asymmetric Henry reactions for 
α-keto esters80 ,we intend to use corresponding derivatives to catalyze the desired 
asymmetric Henry reaction, of which the desired products could be converted to 
natural products and significant biologically molecules of pyrrolidine derivatives. 


















Scheme 2.3 Reaction design for the asymmetric Henry reaction via DKR. 
2.2 Results and discussions 
2.2.1 Reaction optimization 
We selected the Henry reaction of β-substituted α-keto ester 2-10 and 
nitromethane as the model reaction, some bifunctional catalysts were screened 
(Scheme 2.4), and the results are shown in Table 2.1 













































Scheme 2.4 List of preliminary bifunction catalysts screened. 
The thiourea bifunctional catalysts 2-6 (entry 2) and 2-9 (entry 6) were not 
effective. Whereas, C6’-OH cinchona alkaloid derivates catalysts 2-3 (entry 4) 
and 2-7 (entry 3) provided moderate enantioselectives, which indicated C6’-OH 
group is crucial in cinchona alkaloid scaffold for enantiocontrol in this reaction. 
β-ICD 2-8 (entry 5) with C6’-OH group only led to the product with 19% ee, 
demonstrating the importance of quinidine or quinine scaffold in stereochemical 
control. 
Table 2.1 Preliminary catalyst screening for asymmetric Henry reaction[a].  




Entry Catalyst Time Yield[b] dr[c] ee/%[d] 
1 2-5 48h 52 >10:1 13 
2 2-6 48h 55 >10:1 16 
3 2-7 72h 63 >10:1 45 
4 2-3 78h 61 >10:1 67 
5 2-8 85h 49 >10:1 19 
6 2-9 48h 70 >10:1 20 
[a] Reactions were carried out using 2-10 (0.05 mmol), CH3NO2 (0.5 mmol), 
catalyst (0.005 mmol) in 0.125 ml Toluene at room temperature. [b] Isolated yield. 
[c] Determined by 1H NMR analysis. [d] Determined by chiral HPLC analysis.  
With the demonstrated importance of the C6’-OH group in cinchona alkaloid 
derivatives, a comprehensive catalyst screening was performed (Scheme 2.5), and 
the results are summarized in Table 2.2 
The electron withdrawing groups on aromatic ring (2-12 and 2-13) can 
increase enantioselectivity slightly (entry 2 and 3), however, longer reaction time 
was required. Esters 2-15 and 2-16 (entry 5 and 6) gave less satisfactory results. 
Therefore, we chose catalyst 2-3 (entry 1) as the best catalyst for the subsequent. 
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Scheme 2.5 List of comprehensive bifunctional catalysts screened 
Table 2.2 Comprehensive catalyst screening for asymmetric Henry reaction[a]. 
 
Entry Catalyst Time Yield[b] dr[c] ee/%[d] 
1 2-3 72h 61 >95:5 67 
2 2-12 108h 55 >95:5 67 
3 2-13 96h 53 >95:5 70 
4 2-14 36h 68 >95:5 64 
5 2-15 18h 79 >95:5 56 
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6 2-16 96h 42 >95:5 61 
[a] Reactions were carried out using 2-10 (0.05 mmol), CH3NO2 (0.5 mmol), 
catalyst (0.005 mmol) in 0.125 ml solvent at room temperature. [b] Isolated yield. 
[c] Determined by 1HNMR analysis. [d] Determined by chiral HPLC analysis.  
Table 2.3 Solvent screening for asymmetric Henry reaction[a]. 
 
Entry Solvent Time Yield[b] dr[c] ee/%[d] 
1 THF 72h 72 >95:5 67 
2 CH2Cl2 24h 51 >95:5 59 
3 CHCl3 24h 59 >95:5 67 
4 Acetone 72h 70 >95:5 66 
5 Toluene 72h 61 >95:5 67 
6 Et2O 96h 52 >95:5 66 
7 Dioxane 80h 56 >95:5 67 
8 CH3CN 60h 33 >95:5 51 
9 CH3OH 96h - - - 
10 CH3NO2 36h 85 >95:5 56 
11[e] Toluene 72h 70 >95:5 73 
12[f] Toluene 72h 76 >95:5 76 
13[g] Toluene 72h 75 >95:5 75 
MSc. Thesis    Liu Guannan 
34 
 
14[f] CH2Cl2 60h 86 >95:5 68 
15[f] Xylene 72h 82 >95:5 75 
[a] Reactions were carried out using 2-10 (0.05 mmol), CH3NO2 (0.5 mmol), 2-3 
(0.005 mmol) in 0.125 ml solvent at room temperature. [b] Isolated yield. [c] 
Determined by 1HNMR analysis. [d] Determined by chiral HPLC analysis. [e] 
With 3Å molecular sieve. [f] With 4Å molecular sieve. [g] With 5Å molecular 
sieve. 
We performed the Henry reaction between 2-10 and nitromethane catalyzed 
by bifunctional cinchona alkaloid 2-3 in a number of common organic solvents, 
and the results are summarized in Table 2.3. When the Henry reaction carried out 
in protic solvent CH3OH (entry 9), messy results were obtained. For aprotic 
solvents, the decrease of solvent polarity favored the enantioselectivity of the 
Henry product 2-11. Addition of 4Å molecular sieve to toluene (entry 12) led to 
the best result of 76% yield and 76% ee, which seems to indicate the importance 
of hydrogen bonding interactions in our reaction system. 
Further optimizations on reaction temperature, catalyst loading and different 
esters were performed (Table 2.4). Under the optimized reaction conditions at 0 oC, 
the increased ee of 84% was obtained of Henry product 2-11 (entry 3). Decreased 
the concentration to 0.2 M slightly decreased the enantioselectivity as well 
prolong the reaction apparently (entry 4). In the presence of 5 mol % 2-3, 2-11 
was obtained with decreased ee of 73% (entry 5). From entry 1 and 6 - 8, a 
significant improvement of enantioselectity was observed by replaced R group of 
substrate from methyl ester to t-Bu ester. Thus, the best condition was 0.4 M 
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concentration at 0 oC with 10% catalyst loading and 4Å molecular sieve in toluene 
and using t-Bu esters as substrates. 
Table 2.4 Optimization of reaction temperature, catalyst loading and different 
esters[a]. 
 
Entry R Time Yield[b] dr[c] ee/%[d] 
1 Et 48h 76 >95:5 76 
2[e] Et 72h 73 >95:5 84 
3[f] Et 96h 75 >95:5 82 
4[g] Et 96h 80 >95:5 75 
5[h] Et 96h 80 >95:5 73 
6[e] Me 96h 79 >95:5 73 
7[e] i-Pr 68h 95 >95:5 82 
8[e] t-Bu 60h 97 >95:5 86 
[a] Reactions were carried out using 2-10 (0.05 mmol), CH3NO2 (0.5 mmol), 2-3 
(0.005 mmol) in 0.125 ml Toluene with 10 mg 4Å molecular sieve. [b] Isolated 
yield. [c] Determined by 1HNMR analysis. [d] Determined by chiral HPLC 
analysis. [e] The temperature was 0 oC [f] The temperature was -10 oC [g] The 
concentration was 0.2M. [h] Catalyst loading was 5 mol%. 
2.2.2 Substrate scope 
With the established best reaction conditions, we next studied the scope of 
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the asymmetric Henry reaction via DKR with an array of different β-substituted 
α-keto esters (Table 2.5). 
Consistently high diastereoselectivities and enantioselectivities were 
observed for a wide range of β-aromatic methyl di-substituted α-keto esters 
(entries 1 and 3-13). In this substrate scope, we observed good enantioselectivities 
for β-methyl substituate α-keto t-butyl esters with around 80% ee for all the 
relevant entries (entry 1 and 3-13). All the reactions proceeded with 80% ee 
besides the one with ethyl group as a β-substituent, ee dropped to 55% (entry 2). 
In particular, high diastereoselectivities (between 28:1 to >99:1) were attainable 
for β-methyl substituted α-ketoester substrates (entry 1 and 3-13). With ethyl 
group as a β-substituent, diastereoselectivity dropped to 18:1 (entry 2).  
Table 2.5 Substrate scope of 2-3 catalyzed asymmetric Henry reaction via DKR[a]. 
 
Entry 2-10 Ar 2-11 Time Yield[b] dr[c] ee/%[d] 
1 2-10a Ph 2-11a 48h 97 53:1 86 
2[e] 2-10b Ph 2-11b 72h 89 18:1 55 
3 2-10c 3-ClC6H4 2-11c 72h 96 28:1 85 
4 2-10d 3-MeOC6H4 2-11d 48h 96 >99:1 81 
5 2-10e 3-CF3C6H4 2-11e 48h 90 37:1 81 
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6 2-10f 4-ClC6H4 2-11f 72h 95 70:1 83 
7 2-10g 4-BrC6H4 2-11g 72h 93 >99:1 81 
8 2-10h 4-MeC6H4 2-11h 48h 95 >99:1 84 
9 2-10i 4-MeOC6H4 2-11i 60h 96 >99:1 80 
10 2-10j 4-BnOC6H4 2-11j 72h 95 52:1 82 
11 2-10k 2-MeOC6H4 2-11k 72h 88 >99:1 77 
12 2-10l 1-Naphenyl 2-11l 36h 91 >99:1 88 
13 2-10m 2-thiophenyl 2-11m 24h 96 56:1 77 
[a] Reactions were carried out using 2-10 (0.05 mmol), CH3NO2 (0.5 mmol), 2-3 
(0.005 mmol) in 0.125 ml Toluene with 10 mg 4Å molecular sieve at 0 oC. [b] 
Isolated yield. [c] Determined by 1HNMR analysis. [d] Determined by chiral 
HPLC analysis. [e] Ethyl as the β-substituted group. 
2.2.3 Proposed transition state models 
    To offer a stereochemical reasoning, transition state model as shown in 
Scheme 2.6. The tertiary amine moiety of 2-3 first deprotonates the α-proton of 
nitromethane to generate an ammonium ion and carbanion ion pair. At the same 
time, the enol form of substrate α-ketoester interacts with catalyst 2-3 through 
hydrogen bonding and maybe π-π interaction. The subsequent attack of carbanion 
at the carbonyl group from Si face leads to the formation of major enantiomer. 
Due to the steric hindrance of quinuclidine ring, the 4S configuration was favored 
when the enol transforms to ketone of keto-enol tautomerism. 




Scheme 2.6 Proposed transition states models. 















    Scheme 2.7 Coversion of 2-11c to pyrrolidine derivative 2-17. 
The Henry product can be easily converted to pyrrolidine derivative via 
reductive amination (Scheme 2.7). Treated with NaBH4 and NiCl2˙6H2O, 2-11c 
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was converted to 2-17 in 75% yield without losing enantioselectivity.  
2.3 Conclusion 
In summary, the first highly diastereo- and enantioselective organocatalytic 
Henry reaction between β-substituted α-keto esters and nitromethane catalyzed by 
cinchona alkaloid derivatives via DKR was developed. The resulting compounds 
could be readily converted to biologically important pyrrolidine derivatives.  
2.4 Experimental section 
2.4.1 General information 
1H and 13C NMR spectra were recorded on a Bruker ACF300 or DPX300 
(300 MHz) or AMX500 (500 MHz) spectrometer. Chemical shifts were reported 
in parts per million (ppm), and the residual solvent peak was used as an internal 
reference. Multiplicity was indicated as follows: s (singlet), d (doublet), t (triplet), 
q (quartet), m (multiplet), dd (doublet of doublet), br s (broad singlet). Coupling 
constants were reported in Hertz (Hz). Low resolution mass spectra were obtained 
on a Finnigan/MAT LCQ spectrometer in ESI mode, and a Finnigan/MAT 95XL-T 
mass spectrometer in FAB mode. All high resolution mass spectra were obtained 
on a Finnigan/MAT 95XL-T spectrometer. Flash chromatography separation was 
performed on Merck 60 (0.040 – 0.063 mm) mesh silica gel. 
The enantiomeric excesses of products were determined by chiral-phase 
HPLC analysis, using a Daicel Chiralcel AD-H column (250 x 4.6 mm), or Daicel 
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Chiralpak IC column or ID column (250 x 4.6 mm). The diastereomeric ratios of 
products were determined by crude 1H NMR on a Bruker ACF300 or DPX300 
(300 MHz) or AMX500 (500 MHz) spectrometer. 
Catalysts 2-5 was commercial available, 2-3, 2-7, 2-12 to 2-16 were prepared 
according to the literature procedures[73,85]. Catalysts 2-6[86], 2-8[87], 2-9[88] were 
prepared following the literature procedures. Substrate 2-10[89] was prepared 
according to the literature procedures. For all the Henry reaction products 2-11 
and 2-11a-m, the two diastereomers were cannot separated. 
The absolute configuration of 2-11c was assigned by X-ray crystallographic 
analysis, and configurations of other Henry reaction products were assigned by 
analogy. Due to the quite high diastereoselectivies of Henry reaction products 
2-11a to 2-11m, the minor diastereomers are unnecessary to separate out, which 
are also cannot be separated by column in experiments. 
2.4.2 Representative procedure for the Henry reaction 
Asymmetric Henry reaction of tert-butyl 3-methyl-2,4-dioxo-4-phenylbutanoate 
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    To a solution of tert-butyl 3-methyl-2,4-dioxo-4-phenylbutanoate 2-10a (13.1 
mg, 0.05 mmol), nitromethane (31 mg, 0.5 mmol) and 4Å molecular sieve (10 mg) 
in toluene (0.125 mL) was added 2-3 (2.2 mg, 0.005 mmol). The resulting mixture 
was stirred for 48h at 0 oC. After removal of the solvent, the residue was purified 
by flash column chromatography (hexane/EtOAc = 8/1 as an eluent) to afford 
Henry product 2-11a (15.7 mg, 97% yield) as a white solid. The diastereomeric 
ratio was determined by 1H NMR analysis of the crude mixture, and the 
enantiomeric excess was determined by HPLC analysis on a chiral stationary 
phase. 
2.4.3 Representative procedure for synthesizing the substrates. 
Synthesis of tert-butyl-3-methyl-2,4-dioxo-4-(p-tolyl)butanoate 
 
To a solution of 2-18h (0.48 mL, 3 mmol) in THF (10 mL) was slowly added 
a solution of lithium bis(trimethylsilyl)amide (1 mol/L in THF, 4.5 mL, 4.5 mmol) 
in THF (10 mL) via syringe under nitrogen atmosphere at -78 oC (dry ice/acetone 
bath). After stirred for 0.5 h, a solution of imidazol-1-yl-oxo-acetic acid t-butyl 
ester 2-19 (588 mg, 3 mmol) in THF (10 mL) was added via syringe. After that 
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reaction mixture was allowed to warm to room temperature. The obtained mixture 
was stirred for overnight then saturated solution of NH4Cl was added to quench 
the reaction. Then added 20 mL EA and 15 mL H2O, the organic layer was 
separated, dried over anhydrate Na2SO4. After removal of the solvent, the residue 
was purified by flash column chromatography (hexane/EtOAc = 12/1 as an eluent) 
to afford product (0.59 g, 71% yield) as a white solid. 
2.4.4 Representative Method of synthesizing ketone intermediate 
(2-18) 
Synthesis of 1-(naphthalen-1-yl)propan-1-one 
 
To the solution of 1-naphthaldehyde 2-21l (0.80 mL, 5.1 mmol) of THF (20 
mL) slowly added the fresh prepared CH3CH2MgBr (5.5 mmol) solution of THF 
at 0 oC. After stirring for 5 h, saturated NH4Cl solution (20 mL) and EA (25 mL) 
was added to quench the reaction. The aqueous layer was extracted by EA (15 mL 
x 3). Then combined separated organic layer wash by H2O (20 mL x 2) and brine 
(20 mL) and dried by Na2SO4. After removal of solvent by reduced pressure, the 
residue was purified by flash column chromatography (hexane/EtOAc = 20/1 as 
an eluent) to afford product alcohol 2-20l (0.52 g, 54% yield) as a slight yellow 




To the solution of 1-(naphthalen-1-yl)propan-1-ol 2-20l (0.52 g, 2.8 mmol) of 
DCM (20 mL), slow added 4Å Molecular sieve (1.6 g) and NH4OAc (0.56 g, 6.8 
mmol), and then slowly added PCC (0.90 g, 4.1 mmol) to the mixture at 0 oC with 
continued stirring. After overnight stirring, added DCM (50 ml) to dilute, the 
resulted mixture was filtered and the filtrate was washed by H2O (20 mL x 3) and 
brine (20 mL) and dried by Na2SO4, after the removal of solvent under reduced 
pressure, the residue was purified by flash column chromatography 
(hexane/EtOAc = 15/1 as an eluent) to afford product ketone 2-18l (0.34 g, 65% 
yield) as a colorless oil. 
2.4.5 Procedure for synthesizing intermediate t-butyl ester (2-19). 
Synthesis of tert-butyl-2-(1H-imidazol-1-yl)-2-oxoacetate (2-19). 
 
tert-Butyl alcohol (0.28 mL, 3 mmol) was added in one batch to a stirred 
solution of oxalyl chloride (0.27 mL, 3 mmol) in Et2O (25 mL) at 0 oC under N2. 
After 1 h, a solution of imidazole (0.61 g, 9 mmol) in EA (10 mL) was added over 
15 min. After an additional 1 h, the stirred reaction mixture was filtered, and the 
imidazole hydrochloride precipitate was washed with Et2O (20 mL). The solvent 
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Crystal system                     Orthorhombic 
Space group                     P2(1)2(1)2(1) 
Unit cell dimensions                a = 5.7597(4) Å 　   α= 90°. 
b = 17.0971(11) Å 　β= 90°. 
                           c = 17.4304(12) Å  　 γ= 90°. 
Volume                           1716.4(2) Å3 
Z                               4 
Density (calculated)                 1.385 Mg/m3 
Absorption coefficient             0.254 mm-1 
F(000)                           752 
Crystal size                        0.40 x 0.24 x 0.12 mm3 
Theta range for data collection      1.67 to 27.48°. 
Index ranges                      -7<=h<=7, -22<=k<=18, -22<=l<=22 
Reflections collected                12203 
Independent reflections             3943 [R(int) = 0.0468] 
Completeness to theta = 27.48°      99.9 %  
Absorption correction             Semi-empirical from equivalents 
Max. and min. transmission         0.9702 and 0.9053 
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Refinement method                Full-matrix least-squares on F2 
Data / restraints / parameters         3943 / 0 / 222 
Goodness-of-fit on F2               1.047 
Final R indices [I>2sigma(I)]         R1 = 0.0433, wR2 = 0.0933 
R indices (all data)                R1 = 0.0501, wR2 = 0.0968 
Absolute structure parameter          0.02(6) 
Largest diff. peak and hole         0.260 and -0.199 e.Å-3 
2.4.7 Analytical data of substrates 
tert-butyl-3-methyl-2,4-dioxo-4-phenylbutanoate (2-10a) 
 
A white solid; 1H NMR (300 MHz, CDCl3) δ 7.99 - 7.96 (m, 2H), 7.64 - 7.57 (m, 
1H), 7.56 - 7.45 (m, 2H), 4.96 (q, J = 7.1 Hz, 1H), 1.43 (d, J = 7.2 Hz, 3H), 1.41 
(s, 9H).; 13C NMR (75 MHz, CDCl3) δ 198.08, 191.62, 159.32, 135.17, 133.73, 
128.90, 128.67, 84.54, 51.00, 27.55, 12.69.; HRMS (ESI) m/z calcd for C15H18O4 
[M+Na]+ 285.1097, found 285.1108. 
tert-butyl-3-benzoyl-2-oxopentanoate (2-10b) 




A white solid; 1H NMR (300 MHz, CDCl3) δ 8.00 -7.97 (m, 2H), 7.68 – 7.56 (m, 
1H), 7.53 – 7.48 (m, 2H), 4.87 (q, J = 7.3 Hz, 1H), 2.11 – 1.86 (m, 2H), 1.41 (s, 
9H), 0.97 (t, J = 7.4 Hz, 3H).; 13C NMR (75 MHz, CDCl3) δ 196.97, 190.98, 
159.57, 135.94, 133.65, 128.87, 128.63, 84.57, 57.81, 27.56, 21.43, 12.01.; HRMS 
(ESI) m/z calcd for C16H20O4 [M+Na]+ 299.1254, found 299.1258. 
tert-butyl-4-(3-chlorophenyl)-3-methyl-2,4-dioxobutanoate (2-10c) 
 
A white solid; 1H NMR (300 MHz, CDCl3) δ 7.95 (t, J = 1.8 Hz, 1H), 7.88 – 7.82 
(m, 1H), 7.63 – 7.55 (m, 1H), 7.46 (t, J = 7.9 Hz, 1H), 4.90 (q, J = 7.1 Hz, 1H), 
1.44 (s, 9H), 1.42 (d, J = 8.6 Hz, 3H).; 13C NMR (75 MHz, CDCl3) δ 196.78, 
191.08, 159.34, 136.79, 135.32, 133.66, 130.25, 128.71, 126.75, 84.80, 77.42, 
77.00, 76.58, 50.96, 27.61, 12.63.; HRMS (ESI) m/z calcd for C15H17ClO4 
[M+Na]+ 319.0708, found 319.0712. 
tert-butyl-4-(3-methoxyphenyl)-3-methyl-2,4-dioxobutanoate (2-10d) 




A white solid; 1H NMR (500 MHz, CDCl3) δ 7.55 (d, J = 7.7 Hz, 1H), 7.51 – 7.48 
(m, 1H), 7.41 (t, J = 7.9 Hz, 1H), 7.15 (dd, J = 8.2, 2.0 Hz, 1H), 4.93 (q, J = 7.1 
Hz, 1H), 3.86 (s, 3H), 1.44 (d, J = 7.2Hz, 3H), 1.43 (s, 9H); 13C NMR (126 MHz, 
CDCl3) δ 197.85, 191.61, 160.06, 159.35, 136.55, 129.88, 121.29, 120.27, 112.84, 
84.58, 55.47, 51.15, 27.59, 12.78.; HRMS (ESI) m/z calcd for C16H20O5 [M+Na]+ 
315.1203, found 315.1205. 
tert-butyl-4-(4-chlorophenyl)-3-methyl-2,4-dioxobutanoate (2-10f) 
 
A white solid; 1H NMR (500 MHz, CDCl3) δ 7.92 (d, J = 8.6 Hz, 2H), 7.48 (d, J = 
8.6 Hz, 2H), 4.90 (q, J = 7.1 Hz, 1H), 1.43 (s, 9H), 1.41 (d, J = 6.9 Hz, 3H); 13C 
NMR (126 MHz, CDCl3) δ 196.81, 191.22, 159.37, 140.31, 133.57, 130.07, 
129.27, 84.74, 50.91, 27.60, 12.64.; HRMS (ESI) m/z calcd for C15H17ClO4 
[M+Na]+ 319.0708, found 319.0716. 
tert-butyl-4-(4-bromophenyl)-3-methyl-2,4-dioxobutanoate (2-10g) 




A white solid; 1H NMR (500 MHz, CDCl3) δ 7.84 (d, J = 8.6 Hz, 2H), 7.65 (d, J = 
8.6 Hz, 2H), 4.89 (q, J = 7.1 Hz, 1H), 1.43 (s, 9H), 1.42 (d, J = 7.2 Hz, 3H).; 13C 
NMR (126 MHz, CDCl3) δ 197.00, 191.19, 159.36, 133.98, 132.27, 130.14, 
129.05, 84.75, 50.88, 27.61, 12.63.; HRMS (ESI) m/z calcd for C15H1779BrO4 




A white solid; 1H NMR (500 MHz, CDCl3) δ 7.88 (d, J = 8.2 Hz, 2H), 7.30 (d, J = 
8.0 Hz, 2H), 4.94 (q, J = 7.1 Hz, 1H), 2.43 (s, 3H), 1.43 (d, J = 1.6 Hz, 3H), 1.42 
(s, 9H).; 13C NMR (126 MHz, CDCl3) δ 197.72, 191.83, 159.43, 144.74, 132.73, 
129.61, 128.84, 84.49, 50.99, 27.61, 21.70, 12.78.; HRMS (ESI) m/z calcd for 
C16H20O4 [M+Na]+ 299.1254, found 299.1251. 
tert-butyl-4-(4-methoxyphenyl)-3-methyl-2,4-dioxobutanoate (2-10i) 




A white solid; 1H NMR (300 MHz, CDCl3) δ 7.96 (d, J = 8.9 Hz, 2H), 6.98 (d, J = 
8.9 Hz, 2H), 4.92 (q, J = 7.1 Hz, 1H), 3.89 (s, 3H), 1.43 (d, J = 5.4 Hz, 3H), 1.42 
(s, 9H).; 13C NMR (75 MHz, CDCl3) δ 196.63, 191.89, 164.02, 159.46, 131.08, 
128.14, 114.10, 84.44, 55.55, 50.80, 27.61, 12.86.; HRMS (ESI) m/z calcd for 
C16H20O5 [M+Na]+ 315.1203, found 315.1198. 
tert-butyl-4-(4-(benzyloxy)phenyl)-3-methyl-2,4-dioxobutanoate (2-10j) 
 
A white solid; 1H NMR (500 MHz, CDCl3) δ 7.96 (d, J = 8.9 Hz, 2H), 7.34 – 7.44 
(m, 4H), 7.35 (d, J = 7.3 Hz, 1H), 7.05 (d, J = 8.9 Hz, 2H), 5.14 (s, 2H), 4.92 (q, J 
= 7.1 Hz, 1H), 1.42 (d, J = 6.2 Hz, 3H), 1.41 (s, 9H).; 13C NMR (126 MHz, CDCl3) 
δ 196.57, 191.77, 163.07, 159.31, 135.90, 130.99, 128.60, 128.18, 127.36, 114.86, 
84.30, 70.10, 50.70, 27.48, 12.74.; HRMS (ESI) m/z calcd for C22H25O5 [M+Na]+ 
369.1697, found 369.1699. 
tert-butyl-4-(2-methoxyphenyl)-3-methyl-2,4-dioxobutanoate (2-10k) 




A white solid; 1H NMR (500 MHz, CDCl3) δ 7.88 (dd, J = 7.8, 1.8 Hz, 1H), 7.54 
– 7.47 (m, 1H), 7.04 (t, J = 7.5 Hz, 1H), 6.95 (d, J = 8.4 Hz, 1H), 4.89 (q, J = 7.1 
Hz, 1H), 3.86 (s, 3H), 1.46 (s, 9H), 1.40 (d, J = 7.1 Hz, 3H); 13C NMR (126 MHz, 
CDCl3) δ 197.08, 192.11, 159.62, 158.37, 134.62, 131.50, 125.56, 121.13, 111.58, 
84.09, 55.82, 55.16, 27.65, 12.33.HRMS (ESI) m/z calcd for C16H20O5 [M+H]+ 
293.1384, found 293.1384. 
tert-butyl-3-methyl-4-(naphthalen-1-yl)-2,4-dioxobutanoate (2-10l) 
 
A white solid; 1H NMR (300 MHz, CDCl3) δ 8.55 (d, J = 8.1 Hz, 1H), 8.04 (d, J = 
7.6 Hz, 2H), 7.89 (dd, J = 7.9, 1.3 Hz, 1H), 7.61 – 7.52 (m, 3H), 5.07 (q, J = 7.1 
Hz, 1H), 1.47 (d, J = 7.1 Hz, 3H), 1.43 (s, 9H).; 13C NMR (75 MHz, CDCl3) δ 
192.41, 177.42, 163.26, 133.47, 128.42, 128.33, 128.30, 126.75, 125.66, 124.30, 
84.53, 54.22, 27.60, 12.60.; HRMS (ESI) m/z calcd for C19H20NO4 [M+Na]+ 
335.1254, found 335.1254. 
tert-butyl-3-methyl-2,4-dioxo-4-(thiophen-2-yl)butanoate (2-10m) 










A white solid; 1H NMR (500 MHz, CDCl3) δ 7.78 (dd, J = 3.8, 1.0 Hz, 1H), 7.71 
(dd, J = 4.9, 1.0 Hz, 1H), 7.18 (dd, J = 4.9, 3.9 Hz, 1H), 4.76 (q, J = 7.1 Hz, 1H), 
1.49 (d, J = 7.1 Hz, 3H), 1.44 (s, 9H).; 13C NMR (126 MHz, CDCl3) δ 190.94, 
190.06, 159.25, 142.55, 134.82, 133.04, 128.41, 84.74, 52.66, 27.61, 13.12.; 
HRMS (ESI) m/z calcd for C13H16O4S [M+Na]+ 291.0662, found 291.0667. 




A white solid; diastereomeric ratio is 53:1; 1H NMR (500 MHz, CDCl3) δ 7.93 (dd, 
J = 8.4, 1.2 Hz, 2H), 7.64 - 7.57 (m, 1H), 7.50 (t, J = 7.8 Hz, 2H), 4.81 (dd, J = 
47.7, 12.8, 2H), 4.38 (s, 1H), 3.97 (q, J = 7.3 Hz, 1H), 1.38 (s, 9H), 1.34 (d, J = 
7.3 Hz, 3H).; 13C NMR (126 MHz, CDCl3) δ 202.27, 170.69, 133.89, 128.87, 
128.53, 84.37, 78.48, 76.47, 44.06, 27.52, 12.66.; HRMS (ESI) m/z calcd for 
C16H21NO6 [M+Na]+ 346.1261, found 346.1262; the ee value of the major isomer 
was 86%, (determined by Daicel Chiralpak IC column, λ = 254 nm, 5% 
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A white solid; diastereomeric ratio is 18:1; 1H NMR (500 MHz, CDCl3) δ 7.98 (d, 
J = 8.2 Hz, 2H), 7.63 (dd, J = 10.4, 4.1 Hz, 1H), 7.52 (t, J = 7.2 Hz, 2H), 5.01 – 
4.82 (m, 2H), 4.20 (s, 1H), 3.87 (q, J = 10.5 Hz, 1H), 1.95 – 1.83 (m, 2H), 1.40 (s, 
9H), 0.87 (t, J = 6.9 Hz, 3H).; 13C NMR (126 MHz, CDCl3) δ 202.19, 170.73, 
128.77, 128.58, 84.62, 78.20, 76.51, 51.22, 27.51, 21.55, 12.38.; HRMS (ESI) m/z 
calcd for C17H23NO6 [M+Na]+ 360.1418, found 360.1410; the ee value of the 
major isomer was 55%, (determined by Daicel Chiralpak ID column, λ = 254 nm, 





A white solid; diastereomeric ratio is 28:1; 1H NMR (300 MHz, CDCl3) δ 7.93 (t, 
MSc. Thesis    Liu Guannan 
54 
 
J = 1.8 Hz, 1H), 7.89 – 7.80 (m, 1H), 7.63 (ddd, J = 8.0, 2.1, 1.1 Hz, 1H), 7.48 (t, 
J = 7.9 Hz, 1H), 4.87 (dd, J = 29.5, 13.0 Hz, 2H), 4.31 (s, 1H), 3.94 (q, J = 7.3 Hz, 
1H), 1.45 (s, 9H), 1.37 (d, J = 7.3 Hz, 3H).; 13C NMR (75 MHz, CDCl3) δ 200.93, 
170.54, 137.58, 135.26, 133.76, 130.19, 128.57, 126.62, 84.68, 78.26, 76.39, 
44.47, 27.57, 12.63.; HRMS (ESI) m/z calcd for C16H20ClNO6 [M+Na]+ 380.0871, 
found 380.0878; the ee value of the major isomer was 85%, (determined by Daicel 
Chiralpak IC column, λ = 254 nm, 5% i-PrOH/hexanes, flow rate = 1.0 mL/min, 




A white solid; diastereomeric ratio is >99:1; 1H NMR (500 MHz, CDCl3) δ 7.50 
(d, J = 7.7 Hz, 1H), 7.46 – 7.43 (m, 1H), 7.40 (t, J = 7.9 Hz, 1H), 7.18 – 7.12 (m, 
1H), 4.82 (dd, J = 48.7, 12.8 Hz, 2H), 4.34 (s, 1H), 3.93 (q, J = 7.3 Hz, 1H), 3.86 
(s, 3H), 1.39 (s, 9H), 1.33 (d, J = 7.3 Hz, 3H).; 13C NMR (126 MHz, CDCl3) δ 
170.66, 160.06, 129.83, 121.08, 120.23, 112.92, 84.40, 78.50, 76.47, 55.49, 44.35  
27.57, 12.72.; HRMS (ESI) m/z calcd for C17H23NO7 [M+Na]+ 376.1367, found 
376.1369; the ee value of the major isomer was 81%, (determined by Daicel 
Chiralpak ID column, λ = 254 nm, 15% i-PrOH/hexanes, flow rate = 1.0 mL/min, 
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A white solid; diastereomeric ratio is 37:1; 1H NMR (500 MHz, CDCl3) δ 8.17 (s, 
1H), 8.12 (d, J = 7.9 Hz, 1H), 7.87 (d, J = 7.7 Hz, 1H), 7.65 (t, J = 7.8 Hz, 1H), 
4.85 (dd, J = 41.1, 13.1 Hz, 2H), 4.25 (s, 1H), 3.96 (q, J = 7.3 Hz, 1H), 1.41 (s, 
9H), 1.35 (d, J = 7.3 Hz, 3H).; 13C NMR (126 MHz, CDCl3) δ 200.86, 170.58, 
136.76, 131.71, 130.4, 129.58, 125.34, 124.51, 84.81, 78.18, 76.45, 44.58, 27.59, 
12.63.; HRMS (ESI) m/z calcd for C17H20F3NO6 [M+Na]+ 414.1135, found 
414.1121; the ee value of the major isomer was 81%, (determined by Daicel 
Chiralpak ID column, λ = 254 nm, 15% i-PrOH/hexanes, flow rate = 1.0 mL/min, 




A white solid; diastereomeric ratio is 70:1; 1H NMR (500 MHz, CDCl3) δ 7.88 (d, 
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J = 8.7 Hz, 2H), 7.47 (d, J = 8.6 Hz, 2H), 4.82 (dd, J = 44.4, 12.9 Hz, 2H), 4.31 (s, 
1H), 3.91 (q, J = 7.3 Hz, 1H), 1.40 (s, 9H), 1.32 (d, J = 7.3 Hz, 3H).; 13C NMR 
(126 MHz, CDCl3) δ 201.03, 170.64, 140.48, 134.25, 129.95, 129.21, 84.55, 78.27, 
76.44, 44.17, 27.56, 12.64.; HRMS (ESI) m/z calcd for C16H20ClNO6 [M+Na]+ 
380.0871, found 380.0890; the ee value of the major isomer was 83%, 
(determined by Daicel Chiralpak IC column, λ = 254 nm, 5% i-PrOH/hexanes, 




A white solid; diastereomeric ratio is >99:1; 1H NMR (300 MHz, CDCl3) δ 7.80 
(d, J = 8.7 Hz, 2H), 7.64 (d, J = 8.7 Hz, 2H), 4.82 (dd, J = 29.1, 13.0 Hz, 2H), 
4.30 (s, 1H), 3.90 (q, J = 7.3 Hz, 1H), 1.40 (s, 9H), 1.32 (d, J = 7.3 Hz, 3H).; 13C 
NMR (75 MHz, CDCl3) δ 201.23, 170.63, 134.69, 132.21, 130.02, 129.25, 84.57, 
78.26, 76.43, 44.17, 27.56, 12.63.; HRMS (ESI) m/z calcd for C16H2079BrNO6 
[M+Na]+ 424.0366, found 424.0377; C16H2081BrNO6 [M+Na]+ 426.0346, found 
426.0351; the ee value of the major isomer was 81%, (determined by Daicel 
Chiralpak IC column, λ = 254 nm, 5% i-PrOH/hexanes, flow rate = 1.0 mL/min, 
t(minor) = 32.90 min, t(major) = 43.68 min). 






A white solid; diastereomeric ratio is >99:1; 1H NMR (500 MHz, CDCl3) δ 7.83 
(d, J = 8.2 Hz, 2H), 7.29 (d, J = 8.1 Hz, 2H), 4.81 (dd, J = 45.0, 13.1 Hz, 2H), 
4.43 (s, 1H), 3.94 (q, J = 7.3 Hz, 1H), 2.43 (s, 3H), 1.37 (s, 9H), 1.33 (d, J = 7.3 
Hz, 3H).; 13C NMR (126 MHz, CDCl3) δ 201.92, 170.72, 144.99, 133.23, 133.9, 
128.68, 84.23, 78.54, 76.53, 43.84, 27.53, 21.68, 12.70.; HRMS (ESI) m/z calcd 
for C17H23NO6 [M+Na]+ 360.1418, found 360.1405; the ee value of the major 
isomer was 84%, (determined by Daicel Chiralpak ID column, λ = 254 nm, 15% 





A white solid; diastereomeric ratio is >99:1; 1H NMR (500 MHz, CDCl3) δ 7.92 
(d, J = 8.9 Hz, 2H), 6.96 (d, J = 8.9 Hz, 2H), 4.81 (dd, J = 41.6, 13.2 Hz, 2H), 
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4.51 (s, 1H), 3.92 (q, J = 7.3 Hz, 1H), 3.88 (s, 3H), 1.37 (s, 9H), 1.33 (d, J = 7.3 
Hz, 3H).; 13C NMR (126 MHz, CDCl3) δ 200.85, 170.77, 164.24, 130.99, 128.72, 
114.06, 84.12, 78.52, 76.61, 55.55, 43.43, 27.53, 12.78.; HRMS (ESI) m/z calcd 
for C17H23NO7 [M+Na]+ 376.1367, found 376.1372; the ee value of the major 
isomer was 80%, (determined by Daicel Chiralpak ID column, λ = 254 nm, 15% 





A white solid; diastereomeric ratio is 52:1; 1H NMR (500 MHz, CDCl3) δ 7.95 – 
7.89 (m, 2H), 7.46 – 7.38 (m, 4H), 7.36 (d, J = 6.8 Hz, 1H), 7.06 – 7.00 (m, 2H), 
5.15 (s, 2H), 4.81 (dd, J = 43.7, 12.8 Hz, 2H), 4.50 (s, 1H), 3.92 (q, J = 7.2 Hz, 
1H), 1.37 (s, 9H), 1.33 (d, J = 7.3 Hz, 3H).; 13C NMR (126 MHz, CDCl3) δ 
200.80, 170.76, 163.35, 135.91, 130.99, 128.71, 128.32, 127.45, 114.89, 84.14, 
78.49, 76.60, 70.24, 43.44, 27.52, 12.77.; HRMS (ESI) m/z calcd for C23H27NO7 
[M+Na]+ 452.1680, found 452.1663; the ee value of the major isomer was 82%, 
(determined by Daicel Chiralpak ID column, λ = 254 nm, 15% i-PrOH/hexanes, 
flow rate = 1.0 mL/min, t(major) = 39.91 min, t(minor) = 48.58 min). 






A white solid; diastereomeric ratio is >99:1; 1H NMR (300 MHz, CDCl3) δ 7.64 
(dd, J = 7.7, 1.8 Hz, 1H), 7.53 – 7.44 (m, 1H), 7.07 – 6.93 (m, 2H), 4.81 (q, J = 
12.8 Hz, 2H), 4.21 (s, 1H), 4.07 (q, J = 7.2 Hz, 1H), 3.92 (s, 3H), 1.43 (s, 9H), 
1.28 (d, J = 7.2 Hz, 3H); 13C NMR (75 MHz, CDCl3) δ 203.42, 170.99, 158.21, 
134.20, 130.95, 121.04, 111.64, 84.02, 78.80, 76.39, 55.65, 49.31, 27.59, 11.91; 
HRMS (ESI) m/z calcd for C17H23NO7 [M+Na]+ 376.1367, found 376.1351; the ee 
value of the major isomer was 77%, (determined by Daicel Chiralpak ID 
column, λ = 254 nm, 15% i-PrOH/hexanes, flow rate = 1.0 mL/min, t(major) = 




A white solid; diastereomeric ratio is >99:1; 1H NMR (300 MHz, CDCl3) δ 8.40 
(dd, J = 8.1, 1.1 Hz, 1H), 8.02 (d, J = 8.2 Hz, 1H), 7.93 – 7.81 (m, 2H), 7.63 – 
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7.50 (m, 3H), 4.87 (dd, J = 30.6, 12.8 Hz, 2H), 4.36 (s, 1H), 3.97 (q, J = 7.3 Hz, 
1H), 1.44 (s, 9H), 1.35 (d, J = 7.3 Hz, 3H); 13C NMR (75 MHz, CDCl3) δ 205.29, 
170.98, 135.37, 133.92, 133.19, 130.33, 128.47, 128.20, 127.50, 126.75, 125.40, 
124.27, 84.62, 78.73, 76.45, 48.45, 27.63, 12.28.; HRMS (ESI) m/z calcd for 
C20H23NO6 [M+Na]+ 396.1418, found 396.1413; the ee value of the major isomer 
was 88%, (determined by Daicel Chiralpak ID column, λ = 254 nm, 15% 





A white solid; diastereomeric ratio is 56:1; 1H NMR (500 MHz, CDCl3) δ 7.76 (dd, 
J = 3.8, 0.8 Hz, 1H), 7.72 (dd, J = 4.9, 0.9 Hz, 1H), 7.17 (dd, J = 4.8, 4.0 Hz, 1H), 
4.84 (dd, J = 39.9, 13.1 Hz, 2H), 4.28 (s, 1H), 3.73 (q, J = 7.2 Hz, 1H), 1.39 (s, 
9H), 1.37 (d, J = 7.3 Hz, 3H).; 13C NMR (126 MHz, CDCl3) δ 194.24, 170.51, 
143.23, 135.46, 133.23, 128.47, 84.50, 78.22, 76.34, 46.19, 27.48, 13.02.; HRMS 
(ESI) m/z calcd for C14H19NO6S [M+Na]+ 352.0825, found 352.0826; the ee value 
of the major isomer was 77%, (determined by Daicel Chiralpak ID column, λ = 
254 nm, 15% i-PrOH/hexanes, flow rate = 1.0 mL/min, t(major) = 25.94 min, 
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t(minor) = 32.17 min). 
 
A slight red solid; 1H NMR (300 MHz, CDCl3) δ 7.40 (d, J = 3.1 Hz, 1H), 7.38 – 
7.36 (m, 1H), 7.34 (d, J = 9.1 Hz, 1H), 7.29 – 7.27 (m, 1H), 4.91 (d, J = 1.8 Hz, 
1H), 4.21 (ddd, J = 12.3, 11.7, 7.9 Hz, 2H), 3.45 (q, J = 8.0 Hz, 1H), 1.57 (s, 9H), 
1.54 (d, J = 3.5 Hz, 3H); 13C NMR (75 MHz, CDCl3) δ 163.63, 146.36, 134.66, 
129.99, 127.20, 126.86, 125.41, 124.16, 79.68, 77.20, 71.42, 55.46, 50.71, 28.48, 
11.18; LRMS (ESI) m/z calcd for C16H22ClNO3 [M+Na]+ 334.12, found 334.18. 
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